Table 1.
Men |
Women |
Total sample |
|
---|---|---|---|
N (%) | N (%) | N (%) | |
Potential problems | |||
Frequent changes to dose | 31 (18.5) | 31 (25.4) | 62 (21.4) |
Frequency of medical appointments | 34 (20.2) | 23 (18.9) | 57 (19.7) |
Frequency of INR testing | 24 (14.3) | 21 (17.2) | 45 (15.5) |
Interactions with other medications | 18 (10.7) | 25 (20.5) | 43 (14.8) |
Interactions between warfarin and food | 11 (6.5) | 23 (18.9) | 34 (11.7) |
INR, international normalized ratio.